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INTRODUCTION
Biomedical interventions, such as thera-
peutics, vaccines and insecticides, are alone 
insufficient to achieve Sustainable Develop-
ment Goal (SDG) 3—healthy lives and well- 
being for all ages. We also need develop-
ment interventions to tackle the underlying 
determinants of ill- health by reducing depri-
vation and improving living conditions and 
the environment. This recognition formed 
the bedrock of early public health, from 
housing improvements and clean water 
provision in 19th century Europe and North 
America,1 to house screening for malaria 
elimination in the USA and water manage-
ment for historical vector control in Italy, Sri 
Lanka, Panama and Zambia.2 Today, devel-
opment interventions are a basic human 
right and ever more critical in response to 
rapid population growth, urbanisation and 
climate change.
Despite their importance, many devel-
opment interventions remain neglected in 
global health policy. For example, the World 
Health Organization (WHO) recognises 
the need for multisectoral approaches to 
malaria,3 but based on current evidence is 
unlikely to be able to make a strong recom-
mendation for strategies such as house 
screening and the removal of standing water 
to prevent mosquitoes in the environment. 
At the root of this issue lies a one- size- fits- all 
guideline development process designed 
for biomedical interventions, in which 
most development interventions fall short. 
Through rigorous systematic reviews and 
the GRADE process4 (often conducted by 
the Cochrane Collaboration; https://www. 
cochrane. org/), WHO bases guidelines on 
‘high- certainty’ evidence, largely derived 
from randomised control trials (RCTs) 
where there is confidence that the true 
effect of an intervention is similar to the 
estimated effect.
WHY DOES HEALTH POLICY OVERLOOK 
DEVELOPMENT INTERVENTIONS?
Unfortunately, biomedical evidence assess-
ments are ill- suited for evaluating the health 
effects of development interventions for 
three reasons. First, prioritisation of evidence 
from RCTs is inappropriate. Unlike vaccines 
and therapeutics, with homogeneous char-
acteristics, effect size and feasibility, develop-
ment interventions (eg, drainage to reduce 
malaria) are context- specific, necessitating 
numerous iterations of RCTs to generate an 
equivalent evidence base. RCTs of develop-
ment interventions are themselves more chal-
lenging and expensive. Development inter-
ventions are often implemented over large 
areas (eg, installation of piped water). Estima-
tion of a statistically robust effect size neces-
sitates randomisation of an unfeasibly large 
number of areas. The interventions them-
selves can be complex and multifaceted (eg, 
malaria control in Khartoum uses land level-
ling and filling, water pipe repair and inter-
mittent irrigation), complicating estimation 
Summary box
 ► To achieve Sustainable Development Goal (SDG) 
3—healthy lives and well- being for all people—de-
velopment interventions (such as improved housing, 
water and sanitation) are critically needed in addi-
tion to biomedical interventions (such as drugs, vac-
cines and insecticides).
 ► However, many development interventions, such as 
house screening for vector- borne disease control, 
remain neglected in global health policy today.
 ► A major reason for this neglect is a requirement for 
evidence from rigorous systematic reviews and ran-
domised controlled trials, which were designed for 
biomedical interventions and are poorly- suited to 
most development interventions.
 ► A new framework for assessing the health benefits 
of development interventions is urgently needed for 
the health sector to support and fully leverage the 
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of effect sizes. Blinding is impossible. Unlike biomedical 
interventions, development interventions have few finan-
cially viable pathways to scale- up. For all of these reasons, 
few RCTs of development interventions are done. This 
precludes meta- analyses, limits certainty of evidence and 
leads to calls for more RCTs or ‘paralysis by analysis’.
Second, despite trends towards including other types 
of study, many systematic reviews still disregard historical, 
programmatic and observational evidence. The recent 
Cochrane review of housing improvements to prevent 
malaria, the oldest intervention against this disease, 
included only two studies of 4102 screened.5 Third, 
focusing systematic reviews on single health outcomes 
is logical for biomedical interventions, but misses the 
bigger picture for development interventions with wide 
co- benefits (figure 1).6 For example, a re- review of a 
Cochrane- standard systematic review of water, sanitation 
and hygiene interventions’ impact on child diarrhoea 
morbidity examined impacts within studies from a joint 
health and development perspective. Of 27 studies re- ex-
amined, 37% were judged to result in substantial addi-
tional impacts beyond reducing diarrhoea morbidity.6 
Rather than narrow evaluations focused on single health 
outcomes, a better question is ‘How can we harness the 
health benefits of development interventions?’.
LIMITING HEALTH AND DEVELOPMENT
Basing guideline development on biomedical evidence 
assessments alone is problematic for several reasons. 
First, taking a narrow view will impede global health 
goals by limiting our toolbox of interventions. Second, 
a system geared towards biomedical interventions will 
favour continued emphasis on vertical over horizontal 
health programmes among funders and decision- 
makers.7 Horizontal programmes, which are needed for 
most development interventions, take a holistic approach 
by strengthening health systems and community owner-
ship over the long term,7 whereas vertical programmes, 
which are well- suited to delivering drugs, vaccines and 
insecticides, have specific, well- defined and usually 
quantitative objectives, centralised management and 
discrete resources.8 While national ministries of health 
are encouraged to adopt multisectoral and integrated 
approaches to disease control,9 vertical programmes are 
ultimately easier to fund, deliver and evaluate, leading 
to the promotion of targeted, technical solutions with 
clearly measurable outcomes.10 Expanding the guide-
line development process to be more inclusive of devel-
opment interventions is a necessary step to ensuring a 
sustainable approach.
Third, a focus on biomedical evidence assessments 
is a lost opportunity for wider development goals. For 
example, clean water and sanitation are the core goals 
of SDG6. Both are also human rights since ‘everyone has 
the right to (an adequate) standard of living…’.11 Yet 
related Cochrane reviews found ‘insufficient evidence to 
know if source‐based improvements in water supplies… 
consistently reduce diarrhoea’12 and, for interventions 
to improve excreta disposal to prevent diarrhoea, ‘the 
quality of the evidence is generally poor and does not 
allow for quantification of any such effect’.13 Health 
guidelines reliant solely on such systematic reviews will 
constrain development for the poorest in society.6
THE WAY FORWARD: A NEW APPROACH TO ASSESS 
DEVELOPMENT INTERVENTIONS
We advocate the creation of a new approach to assess 
the health benefits of development interventions with 
three considerations. First, we must relax evidence 
criteria, accepting that RCTs may be logistically or ethi-
cally unfeasible. Non- randomised studies (including 
well- conducted before- and- after studies) must be consid-
ered, or systematic reviews will continue to find low- 
certainty evidence. Second, we must measure co- benefits 
of development interventions to avoid implementation 
delays from RCTs focused on single pathogens (figure). 
Third, we must consider the socioeconomic patterning 
of illness and opportunities to address these interlocking 
vulnerabilities. A step in the right direction is the new 
WHO INTEGRATE evidence- to- decision framework that, 
unlike GRADE, can evaluate complex interventions and 
assesses more criteria including human rights.14 But 
further refinement of this framework is needed along-
side learning from other sectors. For example, systematic 
maps enable multiple forms of data to inform environ-
mental policy and could supplement systematic reviews 
in health.15
CONCLUSION
At this pivotal time, the health sector has a critical respon-
sibility to leverage and support the potential of the SDGs, 
but cannot fulfil this within the current policy making 
framework. We urgently need a new framework for 
assessing the health benefits of development interven-
tions to prevent further delays in their implementation 
and to maximise their impact.
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